Selected article for: "average age and early stage"
Author: Tutor, Austin; Unis, Graham; Ruiz, Brent; Bolaji, Olayiwola Akeem; Bob-Manuel, Tamunoinemi
Title: Spectrum of Suspected Cardiomyopathy due to COVID-19: A Case Series
  • Cord-id: up7ept00
  • Document date: 2021_7_3
    • ID: up7ept00
    Snippet: INTRODUCTION: : The effects of COVID-19 on the cardiovascular system remains understudied given the early stage of the pandemic. Several case series and case reports have been published on COVID-19 related cardiomyopathies; however, there is often a lack of baseline echocardiographic data confirming a normal cardiac health prior to infection. Here we examine four patients with preserved left ventricular systolic function on prior echocardiogram who developed de novo cardiomyopathies which follow
    Document: INTRODUCTION: : The effects of COVID-19 on the cardiovascular system remains understudied given the early stage of the pandemic. Several case series and case reports have been published on COVID-19 related cardiomyopathies; however, there is often a lack of baseline echocardiographic data confirming a normal cardiac health prior to infection. Here we examine four patients with preserved left ventricular systolic function on prior echocardiogram who developed de novo cardiomyopathies which following COVID-19 infection. METHODS AND OUTCOMES: : The study comprised of four individuals with an average age of 80.5 years, 75% of which were white males. 50% of cases were suspected to have Takotsubo CM vs. myocarditis while the remaining half were diagnosed as myocarditis. Left ventricular systolic function dropped from a normal range to an average of 30% during COVID-19 infection in these individuals. Moreover, half of the cases later died. CONCLUSION: : In conclusion, the COVID-19 pandemic has demonstrated its ability to cause several serious cardiovascular complications with associated worsening of prognosis. Repeat TTE showed recovery of systolic function in 50% of the patients included. There does not appear to be any correlation between COVID-19 related treatments, age, or level of inflammatory markers in those who recovered systolic function versus those who remained depressed. Given the minimal literature on this topic, it is evident more information is needed to help advance treatment and understanding of COVID-19 induced cardiomyopathies; particularly if the vaccination fails to protect against novel strains of COVID-19 and the virus becomes endemic.

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and acute myocardial injury: 1
    • ace inhibitor and admission prior: 1
    • active infection and acute coronary syndrome: 1
    • active infection and acute illness: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • active infection and admission prior: 1, 2, 3
    • active infection and lv systolic function: 1
    • acute cardiomyopathy and admission prior: 1
    • acute coronary syndrome and admission prior: 1, 2
    • acute illness and admission prior: 1, 2, 3, 4, 5, 6
    • acute myocardial injury and admission hypotensive: 1
    • acute myocardial injury and admission prior: 1
    • acute myocardial injury and lv systolic function: 1
    • admission prior and lv systolic function: 1, 2, 3